hat
Product Description Ibrutinib (USAN, konnen tou kòm PCI-32765) se yon dwòg anticancer vize B-selil malignans. Li se yon inibiton nan oralman administre, selektif ak kovalan nan kinazin briton a tyrosine kinase (BTK). Ibrutinib te devlope pou maladi B-selil adisyonèl ki gen ladan ...
eng
Product Description Ibrutinib (USAN, also known as PCI-32765) is an anticancer drug targeting B-cell malignancies. It is an orally-administered, selective and covalent inhibitor of the enzyme Bruton's tyrosine kinase (BTK). Ibrutinib was developed for additional B-cell malignancies including...